122 related articles for article (PubMed ID: 8943393)
1. DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules.
Stebbins CC; Peterson ME; Suh WM; Sant AJ
J Immunol; 1996 Dec; 157(11):4892-8. PubMed ID: 8943393
[TBL] [Abstract][Full Text] [Related]
2. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
3. Identification of residues in the class II-associated Ii peptide (CLIP) region of invariant chain that affect efficiency of MHC class II-mediated antigen presentation in an allele-dependent manner.
Gautam AM; Yang M; Milburn PJ; Baker R; Bhatnagar A; McCluskey J; Boston T
J Immunol; 1997 Sep; 159(6):2782-8. PubMed ID: 9300699
[TBL] [Abstract][Full Text] [Related]
4. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide.
Zechel MA; Chaturvedi P; Lee-Chan EC; Rider BJ; Singh B
J Immunol; 1996 Jun; 156(11):4232-9. PubMed ID: 8666792
[TBL] [Abstract][Full Text] [Related]
5. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
Neumann J; König A; Koch N
Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
[TBL] [Abstract][Full Text] [Related]
6. Distinct peptide loading pathways for MHC class II molecules associated with alternative Ii chain isoforms.
Bikoff EK; Kenty G; Van Kaer L
J Immunol; 1998 Apr; 160(7):3101-10. PubMed ID: 9531264
[TBL] [Abstract][Full Text] [Related]
7. Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function.
Busch R; Doebele RC; von Scheven E; Fahrni J; Mellins ED
J Immunol; 1998 Jan; 160(2):734-43. PubMed ID: 9551909
[TBL] [Abstract][Full Text] [Related]
8. Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.
Thayer WP; Ignatowicz L; Weber DA; Jensen PE
J Immunol; 1999 Feb; 162(3):1502-9. PubMed ID: 9973407
[TBL] [Abstract][Full Text] [Related]
9. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain.
Fineschi B; Sakaguchi K; Appella E; Miller J
J Immunol; 1996 Oct; 157(8):3211-5. PubMed ID: 8871612
[TBL] [Abstract][Full Text] [Related]
10. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
[TBL] [Abstract][Full Text] [Related]
11. CLIP-region mediated interaction of Invariant chain with MHC class I molecules.
Powis SJ
FEBS Lett; 2006 May; 580(13):3112-6. PubMed ID: 16678175
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling and design of invariant chain peptides with altered dissociation kinetics from class II MHC.
Liang MN; Lee C; Xia Y; McConnell HM
Biochemistry; 1996 Nov; 35(47):14734-42. PubMed ID: 8942634
[TBL] [Abstract][Full Text] [Related]
13. T cell recognition of flanking residues of murine invariant chain-derived CLIP peptide bound to MHC class II.
Naujokas MF; Southwood S; Mathies SJ; Appella E; Sette A; Miller J
Cell Immunol; 1998 Aug; 188(1):49-54. PubMed ID: 9743557
[TBL] [Abstract][Full Text] [Related]
14. Effect of HLA-DM transfection on hen egg lysozyme presentation by T2.Ak cells.
Albert LJ; Ghumman B; Watts TH
J Immunol; 1996 Sep; 157(6):2247-55. PubMed ID: 8805621
[TBL] [Abstract][Full Text] [Related]
15. Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.
Stumptner P; Benaroch P
EMBO J; 1997 Oct; 16(19):5807-18. PubMed ID: 9312039
[TBL] [Abstract][Full Text] [Related]
16. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.
Ghosh P; Amaya M; Mellins E; Wiley DC
Nature; 1995 Nov; 378(6556):457-62. PubMed ID: 7477400
[TBL] [Abstract][Full Text] [Related]
17. The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM.
Peterson M; Sant AJ
J Immunol; 1998 Sep; 161(6):2961-7. PubMed ID: 9743359
[TBL] [Abstract][Full Text] [Related]
18. Antigen presentation and assembly by mouse I-Ak class II molecules in human APC containing deleted or mutated HLA DM genes.
Brooks AG; Campbell PL; Reynolds P; Gautam AM; McCluskey J
J Immunol; 1994 Dec; 153(12):5382-92. PubMed ID: 7989744
[TBL] [Abstract][Full Text] [Related]
19. Exogenous CLIP localizes into endocytic compartment of cells upon internalization: implications for antigen presentation by MHC class II molecules.
Mukherjee R; Chaturvedi P; Lee-Chan E; Singh B
Mol Immunol; 2008 Apr; 45(8):2166-76. PubMed ID: 18279957
[TBL] [Abstract][Full Text] [Related]
20. Expression of invariant chain can cause an allele-dependent increase in the surface expression of MHC class I molecules.
Reber AJ; Turnquist HR; Thomas HJ; Lutz CT; Solheim JC
Immunogenetics; 2002 May; 54(2):74-81. PubMed ID: 12037599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
